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The reaction of pharmacological active protic ionic liquid tris-(2-hydroxyethyl)ammonium
4-chlorophenylsulfanylacetate H+N(CH2CH2OH)3 ∙ (
-OOCCH2SC6H4Cl-4) (1) with zinc or nickel chloride in a ratio of 2:1
affords stable at room temperature powder-like adducts [H+N(CH2CH2OH)3]2 ∙ [M(OOCCH2SC6H4Cl-4)2Cl2]
2-, M = Zn (2),
Ni (3). By recrystallization from aqueous alcohol compound 2 unexpectedly gives Zn(OOCCH2SC6H4Cl-4)2 ∙ 2H2O (4).
Unlike 2, compound 3 gives crystals [N(CH2CH2OH)3]2Ni
2+ · [-OOCCH2SC6H4Cl-4]2 (5), which have a structure of
metallated ionic liquid. The structure of 5 has been proved by X-ray diffraction analysis. It is the first example of the
conversion of a protic ionic liquid into potentially biological active metallated ionic liquid (1→ 3→ 5).Findings
Alkanolammonium salts of inorganic and carbonic acids, also
known as protic ionic liquids (PILs), have been the subject of
many studies [1,2]. Depending on cation and anion structure,
PILs can be liquid (room temperature ionic liquids) [2] or
solid compounds with m.p. up to 100°С and even higher
(176°С [3]). For example, 2-hydroxyethylammonium nitrate,
H3
+NCH2CH2OH ∙ NO3
-, synthesized in 1888, has m.p. 52°С
[4]. At the same time, 2-hydroxy-ethylammonium formiate,
H3
+NCH2CH2OH ∙
-OOCН, represents a typical room
temperature PIL with extremely low freezing point (−82°С)
[5]. Alkanolammonium PILs are used as catalysts in chemical
reactions, as electrolytes in full cells, gas (such as CO2 and
SO2) solvents and crystaline cellulose solvents, for desulfuriza-
tion of fuel, enzymes stabilizers and promoters of their activity
and for protein purification [6-10]. Also, they are employed
for the design of nano-structured compounds [11]. Their tox-
icity and biological degradation have been studied [12,13].* Correspondence: us@chem.uni-potsdam.de
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distribution, and reproduction in any mediumAmong the objects of our previous investigations were
PILs containing cations of biologically active 2-
hydroxyethylamines and anions of aroxy- and aryl(heteryl)
sulfanyl(sulfonyl)acetic acids R1R2N
+H(CH2CH2OH)3-n ∙
(-OOCCH2XR), R = Ar, Het; R1, R2 =H, Alk; X = O, S,
SO2; n = 0–2.
These PILs are air-stable solids (m.p. 37-95оС) or viscous
liquids, well soluble in water and polar solvents, representing
a new class of pharmacologically active substances. Showing
low toxicity (LD50 = 1500–6000 mg/kg), they possess
antiaggregation, antithrombotic, membrane-stabilizing, anti-
oxidant, antisclerotic, adaptogenic, analgesic, cardiotropic,
hypocholesterolemic, hemo- and immunotropic activities.
These PILs protect the mammalians and humans from
shock, toxic stress, alcohol and heavy metal intoxication,
and radiation. Their antitumor activity considerably exceeds
or differs from the effect of the initial biologically active
acids and alkanolamine [14-19].
They also exert pronounced growth-stimulating activ-
ity at very low concentrations (10–4 - 10–10 wt %) toward
beneficial bacteria, yeasts, and fungi used in large-scale
biotechnology processes (white biotechnology [20]) fortral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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[H+N(CH2CH2OH)3]2 · [Zn(OOCCH2SC6H4-Cl-4)2Cl2]
2-
                                           (2) 




Scheme 2 Conversion of compound 2 into compound 4.
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http://journal.chemistrycentral.com/content/7/1/34manufacture of fodder, baker’s yeasts and citric acid, bar-
ley sprouting for the preparation of brewer’s malt, and
breeding of silkworms [21].
Recently we have shown that metallated ionic liquid tris-
(2-hydroxyethyl)amine-bis-(2-methylphenoxyacetate)zinc
N(CН2СН2ОН)3Zn
2+ · 2(-ООССН2OC6H4-Me-2) exhibits
a pronounced anti-sclerotic effect [22].
We have assumed that the incorporation of essential
metals (so-called “metals of life”), which are of vital im-
portance for all living organisms: Ca, Mg, Zn, Mn, Cu, Fe,
Co, Ni, etc. [23,24], can enhance or alter the biological ac-
tivity of protic alkanolammonium ionic liquids.
To reach this goal, in this work we have studied
the reaction of PIL tris-(2-hydroxyethyl)-ammonium 4-
chlorophenylsulfanylacetate (1) (a non-toxic compound
possessing antithrombotic, antioxidant and immunotropic
activity) with Zn and Ni chlorides.
The interaction of 1 with metal salts furnishes powder
compounds 2 and 3 (Scheme 1).
According to the data of IR spectroscopy, the
compounds 2 and 3 contain coordination bonds HО···M
with the ОН groups of two molecules of protonated
triethanolamine and coordination bonds M-О with two
carboxylate anions of 4-chlorophenylsulfanylacetic acid.
So, the IR spectrum of 3 shows the absorption bands
ν(Ni-ОС) 396 cm-1, νas(COO
−) and νs(COO
−) at 1583
and 1401 cm-1, Δν = νas(COO
−) - νs(COO
−) = 182 cm-1,
characterizing bidentate coordination bonds of nickel
atom with carboxylate anions; absorption bands typical
for protonated triethanolamine HN+(CH2CH2OH)3 at
548, 549 and 397 cm-1, ν(N+H) is a broad band at 2500–
2700 cm-1; absorption band of the OH group at
3312 cm-1.
Powders 2 and 3 are stable at room temperature. How-
ever, on storage in solutions of organic solvents they
change their composition and structure. So, for example,
when recrystallized from aqueous alcohol (75°C), the pow-
der adduct 2 is unexpectedly converted into zinc di-(4-
chloro-phenylsulfonyl) acetate dihydrate 4 (Scheme 2).
Unlike compound 2, compound 3 forms crystals 5
(Scheme 3).
The structure of compound 5 was established by X-ray
crystal structure analysis. The molecular structure with
the atom labeling scheme is given in Figure 1. The
packing diagram is shown in Figure 2.2 [H+N(CH2CH2OH)3 · (
-OOCCH2SC6H4-Cl-4)]  + ClM 2 →
                                        (1)
→   2 [H+N(CH2CH2OH)3] · [M(OOCCH2SC6H4-Cl-4)2Cl2]2-
                                               (2, 3)
Scheme 1 Synthesis of compounds 2 (M = Zn) and 3 (M = Ni).The Ni(II) cation is coordinated by four oxygen atoms
of the hydroxyl groups and two nitrogen atoms forming
an weakly distorted octahedral coordination environment.
The asymmetric unit contains only the half of the cationic
moiety. Because nickel is located on an inversion centre
the second half is generated by inversion. The nitrogen
atoms occupy the trans positions of the coordination poly-
hedron. Resulting from symmetry, the Ni-N bond lengths
are equal being 2.097(2) Å, and the N-Ni-N bond angle is
180°. The Ni-O distances are 2.062(2) Å and 2.070(2) Å.
One hydroxyl group of each ethanol substituent is not
involved in the coordination and directed away from the
coordination centre. The N-Ni-O bond angles range from
81.50(7)° to 98.50(7)° and the O-Ni-O bond angles be-
tween 85.12(7)° and 94.88(7)°. Previously, structures
containing the bis(triethanolamine)nickel (II) cation were
described [25,26]. The 4-chloro-phenylsulfanyl unit is pla-
nar. The acetate substituent and the phenyl ring are almost
in a tetrahedral arrangement with a C-S-C angle of 101.4
(1)°. The carboxylic group is rotated around the S-C bond
characterized by a C-S-C-C torson angle of −50.7(3)°.
Cations and anions are linked by hydrogen bonds (see
Figure 2). All oxygen atoms of the OH groups of tris-(2-
hydroxy-ethyl)amine are involved in hydrogen bonds.
Strong hydrogen bonds can be observed between those
oxygen atoms, which are coordinated to the metal centre
and both oxygen atoms of one carboxylic moiety. More
weak hydrogen bonds are formed between the non-
coordinated peripheric oxygen atoms of the OH groups
and one oxygen atom of a carboxylic group. One oxygen
atom (O4) of the carboxylic group forms bifurcurated
hydrogen bonds, one to the coordinated oxygen atom O3
and another one to the noncoordinated oxygen atom O3.
That leads to a three-dimensional polymeric network.
Experimental
IR spectra (ν, cm–1) were recorded on a Varian 3100 FT-
IR75 spectrophotometer (KBr). NMR spectra (δ, ppm)
were measured on a DPX 400 instrument at 25°С.
Reflections were collected using a STOE Imaging Plate
Diffraction System (IPDS-II) at 210 K. The data were
corrected for Lorentz, polarisation and extinction effects.
No absorption correction was applied. The structure was
solved by direct methods as implemented in the pro-
gram SHELXS-97 [27]. The refinement was carried out











Scheme 3 Conversion of compound 3 into compound 5.
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http://journal.chemistrycentral.com/content/7/1/34were refined anisotropically. The hydrogen atoms of the
phenyl groups were calculated in their expected
positions. All the other hydrogen bonds were located
from the difference Fourier map. The hydrogen atoms
were refined isotropically. For the phenyl and methylene
hydrogen atoms a riding model was used. The other
hydrogen atoms were free refined. For the visualisation
of the structure the program DIAMOND [29] was ap-




(1) [30] was synthesized in the following manner. To aFigure 1 Molecular structure of 5, showing the atom labelling.
The bis-[tris-(2-hydroxyethyl-amine)]-nickel(II) cation
is centrosymmetric.solution of 4-chlorophenylsulfanylacetic acid 4-Cl-C6H4
SCH2COOH (20.25 g, 0.1 mol) in MeOH (100 ml), was
added dropwise a methanol (50 ml) solution of tris-
(2-hydroxyethyl)amine (14.92 g, 0.1 mol). The mixture
was stirred at 25°C for 30 min. The solvent was distilled
in vacuum. The solid residue was repeatedly washed
with ether and dried in vacuum to afford colorless pow-
der (34.64 g, 98.5% yield), m.p. 90–92°C. For analytical
characterization - see [30].
Compound (2): To the solution of 7.03 g (0.02 mol) of
1 (m.p. 91°С) in 20 ml of МеOН the solution of 1.63 g
(0.01 mol) ZnCl2 · 1.5Н2O in 5 ml of МеOН was added
dropwise. The reaction mixture was stirred at 25°С for
12 h, the solvent was removed in a vacuum. The solid
residue was thoroughly washed with ether and dried
over Р2O5 in a vacuum. 2 (3.71 g, 43%) of colorless pow-
der was obtained, m.p. 152°С, readily soluble in alcohols
and moderately in H2O. IR: 1439 νs(COO), 1553 νas
(COO), 3305 (ОН). 1Н NMR (100 MHz, d4-methanol):
7.30 -7.23 (4H, m, С6Н4), 3.84 (6H, t, OСН2), 3.63 (2H
br s, SСН2), 3.28 (6H, t, NСН2).
13С NMR (400 MHz,
d4-methanol): 174.82 (С =O), 135.84-128.2 (С6Н4),
55.52 (OСН2), 55.20 (NСН2), 37.37 (SСН2). Anal. Calc.
for С28Н44O10S2N2Cl4Zn: С 40.00; Н 5.24; Cl 16.90; S
7.62; Zn. 7.78. Found: С 39.67; Н 5.78; Сl 16.97; S 8.26;
Zn 7.82.
Compound (3): To the solution of 1 (0.703 g, 0.002 mol)
in methanol (10 ml) was added dropwise a methanol
solution (10 ml) of NiCl2 · 6H2O (0.237 g, 0.001 mol). The
reaction mixture was stirred at 25°С for 15 h. The solvent
was distilled in vacuum to give light-green powder 3, m.p.
170°С. Yield 0.55 g (59%). Well soluble in Н2О, less soluble
in alcohols. IR: 1401 νs(COO), 1583 νas(COO), 3312 (ОН).
1Н NMR (100 MHz, d4-methanol): 7.33-7.01 (4Н, m,
С6Н4S), 3.91 (6Н, t, ОСН2), 3.65 (2Н, c, SСН2), 3.44 (6Н, t,
NСН2).
13С NMR (400 MHz, d4-methanol): 177.09 (С = О),
131.76 –128.25 (С6Н4S), 55.33 (ОСН2), 54.98 (NСН2), 37.69
(SСН2). Anal. Calc. for С28Н44Cl4N2О10S2Ni: C 40.30; H
5.27; Cl 17.01; Ni 7.04. Found: C 41.13; H 4.99; Cl 17.29;
Ni 6.88.
Zinc di-(4-chlorphenylsulfanyl)acetate dihydrate (4): 0.5 g
of 2 was dissolved in 10 ml of aqueous alcohol upon stir-
ring (75°C), the solution was kept for one month at room
temperature and filtered. The solid residue was washed
with ether and dried over Р2O5 to obtain colorless plate
crystals 4 with m.p. 202°С. IR: 1416 νs(COO), 1540 νas
Figure 2 Crystal packing of 5, illustrating the hydrogen bonds (dashed lines). Hydrogen bonds geometry: O1∙∙∙O4'' 2.583(2) Å, H1∙∙∙O4''
2.00(3) Å, O1-H1∙∙∙O4'' 171(5)°; O2∙∙∙O5'' 2.563(2) Å, H2∙∙∙O5'' 1.87(3) Å, O2-H2∙∙∙O5'' 177(3)°; O3∙∙∙O4 2.886(3) Å, H3∙∙∙O4 2.13(3) Å, O3-H3∙∙∙O4
158(3)°. Symmetry operator: '' x-1, y, z.
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7.31-7.21 (4H, m, С6Н4), 3.63 (2H, br.s, SСН2).
13С NMR
(400 MHz, d4-methanol): 175.02 (С = O), 131.80-128.65
(С6Н4), 37.37 (SСН2). Anal. Calc. for С16Н16O6S2Cl2Zn: С
38.01; Н 3.17; Zn 12.95. Found: С 38.17; Н 3.18; Zn 12.82.
Bis-[(tris-2-hydroxyethyl)ammonium]nickel(II) di-(4-chlor-
phenylsulfanyl)acetate (5): From a solution 3 (aqueous al-
cohol, 75°C), the blue crystals 5 were obtained (20°C, for
one month), m.p. 176о С. 1Н NMR (100 MHz, d4-metha-
nol): 7.13-6.79 (4Н, m, С6Н4S), 3.49 (6Н, t, ОСН2), 3.29
(2Н, c, SСН2), 2.67 (6Н, t, NСН2).
13С NMR (400 MHz,
d4-methanol): 178.90 (С = О), 136.16 -128.40 (С6Н4S),
56.50 (ОСН2), 54.43 (NСН2), 37.62 (SСН2). Anal. Calc.
for C28H42Cl2N2O10S2Ni: C 44.18; H 5.79; Cl 9.33; Ni
7.72. Found: С 43.88; Н 5.63; Cl 9.54; Ni, 8.01.
Crystal data of 5
C28H42Cl2N2NiO10S2, M = 760.37, triclinic, a = 8.0020
(8), b = 9.4980(10), c = 11.6401(12) Å, V = 823.29(15) Å3,
T = 210(2) K, space group P-1 (no.2), Z = 1, μ(MoKα) =
0.936 mm-1; 5252 reflections measured, 2714 unique(Rint = 0.031) which were used in all calculations. Final
R values: wR2(F
2) = 0.0603, R1 = 0.0445 (all data); wR2
(F2) = 0.0575, R1 = 0.0300 [I > 2σ)].
Conclusion
The reaction of pharmacological active ionic liquid H
+N(CH2CH2OH)3 ∙ (
-OOCCH2SC6H4Cl-4) (1) with zinc
or nickel chloride affords stable at room temperature
powder-like adducts [H+N(CH2CH2OH)3]2 ∙ [M(OOC
CH2SC6H4Cl-4)2Cl2]
2-, M = Zn (2), Ni (3). By recry-
stallization compound 2 unexpectedly gives Zn(OO
CCH2SC6H4Cl-4)2 ∙ 2H2O (4). Unlike 2, compound
3 gives crystals [N(CH2CH2OH)3]2Ni
2+ · [-OOCCH2
SC6H4Cl-4]2 (5), which have a structure of metallated
ionic liquid. It is the first example of the conversion of
a protic ionic liquid into metallated ionic liquid (com-
pound 1→ 3→ 5). The structure of 5 has been proved
by X-ray diffraction analysis. The investigation of
physiological activity of metallated ionic liquids will be
conducted in a new future.
Mirskova et al. Chemistry Central Journal 2013, 7:34 Page 5 of 5
http://journal.chemistrycentral.com/content/7/1/34Additional file
Additional file 1: Crystallographic information. Contains all relevant
CIF information.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SNA carried out the synthetic experiments and drafted the manuscript. ANM
has formulated the research idea and prepared the manuscript draft version.
RGM prepared the manuscript for submission and coordinated final
formulation. US collected the X-ray data and performed the structure
solution. All authors read and approved the final manuscript.
Author details
1A. E. Favorsky Irkutsk Institute of Chemistry, Siberian Branch, Russian
Academy of Sciences, 1 Favorsky Str, 664033 Irkutsk, Russia. 2University of
Potsdam, Institute of Chemistry, Karl-Liebknecht-Str. 24-25, D-14476 Potsdam,
Germany.
Received: 5 December 2012 Accepted: 11 February 2013
Published: 19 February 2013
References
1. Wasserscheid P, Welton T: Ionic liquids in synthesis wiley-VCH GmbH & KGaA.
Germany: Weinheim; 2008.
2. Hallett JP, Welton T: Room-temperature ionic liquids: solvents for
synthesis and catalysis. 2. Chem Rev 2011, 111:3508–3576.
3. Bica K, Rijksen C, Nieuwenhuyzen M, Rogers RD: In search of pure liquid
salt forms of aspirin: ionic liquid approaches with acetylsalicylic acid and
salicylic acid. Phys Chem Chem Phys 2010, 12:2011–2017.
4. Gabriel S: Ueber vinylamin und bromäthylamin. 2. Chemische Berichte
1888, 21(2):2664–2669.
5. Bicak N: A new ionic liquid: 2-hydroxy ethylammonium formate.
J Mol Liquids 2005, 116:15–18.
6. Alizadeh A, Khodaei MM, Eshghi A: Ambiphilic dual activation role of a
task-specific ionic liquid: 2-hydroxyethylammonium formate as a
recyclable promoter and medium for the green synthesis of β-
nitrostyrenes. J Org Chem 2010, 75:8295–8298.
7. Zhang Q, Zhang S, Deng Y: Recent advances in ionic liquid catalysis.
Green Chem 2011, 13:2619–2637.
8. Pinkert A, Marsh KN, Pang S: Alkanolamine ionic liquids and their inability
to dissolve crystalline cellulose. Ind Eng Chem Res 2010, 49:11809–11813.
9. Mann JP, McCluskey A, Atkin R: Activity and thermal stability of lysozyme
in alkylammonium formate ionic liquids - influence of cation
modification. Green Chem 2009, 11:785–792.
10. Hekmat D, Hebel D, Joswig S, Schmidt M, Weuster-Botz D: Advanced
protein crystallization using water-soluble ionic liquids as crystallization
additives. Biotechnol Lett 2007, 29:1703–1711.
11. Greaves TL, Kennedy DF, Mudie ST, Drummond SJ: Diversity observed in
the nanostructure of protic ionic liquids. J Phys Chem B 2010,
114:10022–10031.
12. Pavlovica S, Zicmanis A, Gzibovska E, Klavins M, Peteris M: (2-Hydroxyethyl)
ammonium lactates - highly biodegradable and essentially Non-toxic
ionic liquids. Green Sustain Chem 2011, 1:103–110.
13. Wood N, Ferguson JL, Nimal Gunaratne HQ, Seddon KR, Goodacre R,
Stephens RG: Screening ionic liquids for use in biotransformations with
whole microbial cells. Green Chem 2011, 13:1843–1851.
14. Kolesnikova OP, Mirskova AN, Adamovich SN, Mirskov RG, Kudaeva OT,
Voronkov MG: Alkanolammonium salts of o-cresoxy- and p-
chlorocresoxyacetic acids as immunopoiesis modulators and cytostatics.
Dokl Biol Sci 2009, 425:107–111.
15. Voronkov MG, Sofronov GA, Starchenko DA, Adamovich SN, Mirskova AN:
Protective properties of chlorocresacine against adverse impact of
electromagnetic radiation. Dokl Biol Sci 2009, 428:398–402.
16. Mirskova AN, Adamovich SN, Mirskov RG, Voronkov MG:
Tris-(2-hydroxyethyl)ammonium 2-methyl- and 2-methyl-4-
chlorophenoxyacetate serve as effective inhibitors of thrombocyte
aggregation and antioxidants. Dokl Biol Sci 2010, 433:244–246.17. Mirskova AN, Mirskov RG, Adamovich SN, Voronkov MG: Indole-3-ylsulfonyl
acetate tris-(2-hydroxy-ethyl)ammonium is an effective antioxidant and
cell membranes stabilizer. Dokl Biol Sci 2010, 435:390–392.
18. Mirskova AN, Levkovskaya GG, Kolesnikova OP, Perminova OM, Rudyakova
EV, Adamovich SN: Directed synthesis and immunoactive properties of
(2-hydroxyethyl)ammonium salts of 1-R-indol-3-ylsulfanyl-(sulfonyl)
alkanecarboxylic acids. Russ Chem Bull (Engl Transl) 2010, 59:2236–2246.
19. Mirskova AN, Mirskov RG, Adamovich SN, Voronkov MG: 2-
Hydroxyethylammonium salts organylsulfanyl(sulfonyl)acetic acids - new
pharmacolocical compounds. Russ J Chem Sustainable Develop (Engl Transl)
2011, 19:467–478.
20. Gupta MN, Raghava S: Relevance of chemistry to white biotechnology.
Chem Central J 2007, 1:17.
21. Mirskova AN, Levkovskaya GG, Mirskov RG, Voronkov MG:
Hydroxyalkylammonium salts of organylsulfanyl(sulfonyl)acetic acids -
New stimulators of biological processes. Russ J Org Chem 2008,
44:1478–1485.
22. Rasulov MM, Voronkov MG, Nurbekov MK, Zvereva MV, Mirskova AN,
Adamovich SN, Mirskov RG: Complex bis-(2-methylphenoxyacetate)zinc
with tris-2(hydroxyethyl)amine - as a activator of synthesis of total
triptophanyl - tRNA-synthetase. Dokl Biol Sci 2012, 444:219–222.
23. Gielen M, Tiekink ERT: Metallotherapeutic drugs and metal-based diagnostic
agent. The use of metals in medicine. Chichester, UK: Wiley & Sons Ltd; 2005.
24. Oberleas D, Harland BF, Skalny AV: The biological role of macro and trace
elements in humansand animals. St. Petersburg: Nauka; 2008.
25. Guo H-X, Du ZX, Li XZ: Bis(triethanolamine)nickel(II) sulfate. Acta
Crystallogr Sect E Struct Rep 2009, 65:m810–m811. Online available. http://
journals.iucr.org/e/issues/2009/07/00/pk2167/pk2167.pdf.
26. Haukka M, Kirillov AM, Kopylovich MN, Pombeiro AJL: Bis(triethanolamine-
κ3N,O,O’)nickel(II) benzene-1,4-dicarboxylate. Acta Crystallogr Sect E Struct
Rep 2005, 61:m2746–m2748. Online available. http://journals.iucr.org/e/
issues/2005/12/00/rn6069/index.html.
27. Sheldrick GM: SHELXS-97: Program for the solution of crystal structures.
Germany: University of Göttingen; 1997.
28. Sheldrick GM: SHELXL-97, Program for the refinement of crystal structures.
Germany: University of Göttingen; 1997.
29. Brandenburg K: Diamond. Version 31st edition. Bonn: Crystal Impact; 2005.
30. Levkovskaya GG, Guseva SA, Kazimirovskaya VB, Kholdeeva LN, Voronkov
MG, Мirskova AN: 2-Hydroxyalkylammonium salts aryltioacetic asides and
there influense on functional activity of trombosides. II. Russ Chem Pharm
J 1986, 22:295–300.
doi:10.1186/1752-153X-7-34
Cite this article as: Mirskova et al.: Reaction of pharmacological active
tris-(2-hydroxyethyl)ammonium 4-chlorophenylsulfanylacetate with
ZnCl2 or NiCl2: first conversion of a protic ionic liquid into metallated
ionic liquid. Chemistry Central Journal 2013 7:34.Open access provides opportunities to our 
colleagues in other parts of the globe, by allowing 
anyone to view the content free of charge.
Publish with ChemistryCentral and every
scientist can read your work free of charge
W. Jeffery Hurst, The Hershey Company.
available free of charge to the entire scientific community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central
yours     you keep the copyright
Submit your manuscript here:
http://www.chemistrycentral.com/manuscript/
